MEDISON PHARMA
Medison Pharma is the provider of commercialized therapy products intended for biotech, and pharmaceutical companies. The company offers products in the fields of pharmaceuticals, medical devices, diagnostic products, and provides a complete spectrum of integrated services, helping companies to save, and improve the lives of patients suffering from the most challenging diseases.
MEDISON PHARMA
Industry:
Biotechnology Information Technology
Founded:
1996-01-01
Status:
Active
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content Pound Sterling Japanese Yen IIS 8 Bezeq International
Similar Organizations
CAE
CAE is a world leader in providing simulation and modelling technologies and integrated training solutions for the civil aviation industry.
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-03-04 | Keros Therapeutics | Medison Pharma investment in Series C - Keros Therapeutics | 56 M USD |
2019-01-08 | Keros Therapeutics | Medison Pharma investment in Series B - Keros Therapeutics | 23 M USD |
Key Employee Changes
Date | New article |
---|---|
2022-01-20 | Victor Papamoniodis Joins Medison Pharma as VP International Markets |
More informations about "Medison Pharma"
Medison Pharma - Always Ahead
Medison created the first global commercialization platform to accelerate access to highly innovative therapies developed by leading biotech and pharma companies, helping to save โฆSee details»
Medison Pharma โ About us
Medison is a global pharma company focused on providing access to highly innovative therapies in international markets, helping to save and improve the lives of patients suffering from the most challenging diseasesSee details»
Medison Pharma - LinkedIn
Medison is the first to create an international commercialization platform for highly innovative therapies, helping to save and improve lives by making the best available novel treatments...See details»
Meir Jakobsohn, Founder and CEO - Medison
Meir founded Medison in 1996 and is Medisonโs Executive Chairman, spearheading Medisonโs growth to become a leading global pharma company. Meir is Medisonโs controlling shareholder. Since its inception and until May โฆSee details»
Medison - Crunchbase Investor Profile & Investments
Medison is a pharma company that offers therapy products. Samsung Medison acquired the French AI ultrasound startup Sonio for $92.7 million. View contacts for Medison to access new leads and connect with decision-makers. Medison โฆSee details»
Medison Pharma - Overview, News & Similar companies - ZoomInfo
Aug 11, 2024ย ยท Who is Medison Pharma. Medison is a global pharma company focused on providing access to highly innovative therapies to patients in international markets.See details»
Sarah Otten Joins Medison Pharma as VP, GM โฆ
Jan 9, 2023ย ยท Organization Profile. /CNW/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets...See details»
Medison Pharma Announces Agreement with Regeneron โฆ
ZUG, Switzerland, Jan. 8, 2024 /CNW/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets,...See details»
Medison Pharma - PitchBook
Medison Pharma was founded in 1996. Where is Medison Pharma headquartered? Medison Pharma is headquartered in Petah Tikva, Israel. What is the size of Medison Pharma? Medison Pharma has 350 total employees. โฆSee details»
Medison Pharma Announces the Expansion of its Partnership
PETACH TIKVAH, Israel, Aug. 16, 2022 /CNW/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international...See details»
Medison Pharma โ Our Markets
Medison is the creator and leader of the global partnership category, disrupting the global commercialization paradigm by utilizing its unique platform to commercialize highly innovative therapies worldwide.See details»
Immunocore and Medison Pharma Partner for Future โฆ
Oct 18, 2021ย ยท Medison is the first to create an international commercialization platform for highly innovative therapies, helping to save and improve lives by making the best available novel โฆSee details»
Medison Pharma and Alnylam Pharmaceuticals Announce โฆ
Apr 30, 2024ย ยท Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies for patients in international markets, and Alnylam โฆSee details»
Medison Pharma Announces the Approvals by Health Canada and โฆ
Jun 8, 2022ย ยท Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional โฆSee details»
Medison Pharma โ Newsroom
Read the latest updates on Medison a global pharma company focused on providing access to highly innovative therapies in international markets. About Us Our MarketsSee details»
Medison Pharma Announces Extension of Multi-territorial โฆ
PETACH TIKVAH, Israel, May 23, 2022 /PRNewswire/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in...See details»
Moderna Inks Deal with Medison Pharma; Shares Up 6.6%
Jun 8, 2021ย ยท The shares of the pharmaceutical and biotechnology company, Moderna Inc. (MRNA), rose 6.6% to $219.57 on June 7 after it joined hands with Medison Pharma to market โฆSee details»
Ipsen and Medison Pharma Announce Health Canada Approval of โฆ
Nov 13, 2023ย ยท Medison and Ipsen are part of a multiregional partnership in both Canada and Israel to bring Bylvay, a highly innovative therapy for the treatment of pruritus due to PFIC, โฆSee details»
Medison Pharma | Drug Developments | Pipeline Prospector
Apr 30, 2024ย ยท Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Medison PharmaSee details»
Product Monographs - Medison
List of medicines that Medison currently markets in Canada, including product monographs and patient medication information.See details»